Upgrade of Our Keratinocyte Cell Culture Portfolio

We have expanded our Keratinocyte Cell Culture Portfolio with the addition of an improved animal-extract free Keratinocyte Growth Medium 3 for the standardized isolation and expansion of juvenile and adult Normal Human Keratinocytes.

We have now launched an upgrade to our well-established Keratinocyte Cell Culture Portfolio featuring:

  • Our optimized animal-extract free Keratinocyte Growth Medium 3
  • Normal Human Keratinocytes isolated in animal-extract free Keratinocyte Growth Medium 3 from the epidermis of pooled or single juvenile and adult donors.

We support researchers with the standardization of dermal cell culture by providing an optimized growth medium for the isolation and cultivation of keratinocyte which is free of undefined animal components such as bovine pituitary extract (BPE) and fetal calf serum (FCS). The advanced Keratinocyte Growth Medium 3 ensures a cell culture environment with less batch-to-batch variation to improve controlled keratinocyte culture and reproducibility of results.

Advantages:

  • The highest degree of standardization achieved by optimized BPE- and serum-free formulation
  • Supports fast proliferating and homogenous cell population of Normal Human Keratinocytes
  • No need for extracellular matrix coating or feeder cells
  • Increased isolation efficiency of Normal Human Keratinocytes

 

Interested in testing our Keratinocyte Growth Medium 3 ?

Contact us now and give us your contact details. One of our scientific specialists will get in touch to handle your request.

Request trial discount

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Luxembourg
    15. Monaco
    16. Netherlands
    17. Norway
    18. Poland
    19. Portugal
    20. Romania
    21. Slovakia
    22. Slovenia
    23. Spain
    24. Sweden
    25. Switzerland
    26. United Kingdom
  3. Asia
    1. India
    2. Israel
    3. Japan
    4. Malaysia
    5. Singapore
    6. South Korea
    7. Taiwan
    8. Thailand
Scroll to top